$NYXH News

Nyxoah SA (NYXH) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Piper Sandler Reiterates Overweight on Nyxoah, Lowers Price Target to $7

Nyxoah SA (NYXH) Q1 2026 Earnings Call Transcript

Nyxoah Reports Q1 2026 Results: Full Earnings Call Transcript

Nyxoah Sees FY2026 Sales $42.156M-$46.840M vs $37.200M Est

Nyxoah Q1 EPS $(0.43) Beats $(0.54) Estimate, Sales $7.462M Beat $7.130M Estimate

Stifel Downgrades Nyxoah to Hold, Lowers Price Target to $5

Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

How The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed Targets

Nyxoah to Participate in the Bank of America 2026 Healthcare Conference

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $8

Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87

Cantor Fitzgerald Reiterates Overweight on Nyxoah, Maintains $11 Price Target

Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026

Publication relating to transparency notifications

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $10

Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges

Nyxoah (NYXH) Q4 2025 Earnings Call Transcript

Nyxoah Q4 Earnings Call Highlights